Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation

Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery

“…24 -27 Compton et al 24 reported no major adverse outcomes in 28 patients undergoing 41 major noncardiac surgical procedures with a median time from drug-eluting stent implantation to surgery of 260 days. Brotman et al 25 also reported a low incidence of adverse outcomes in 114 patients undergoing noncardiac surgery with a median of 236 days from drug-eluting stent implantation.…”

2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

“…[108][109][110][111][112][113] The risk relates to the nature of the underlying ACHD, the surgical procedure, and the urgency of intervention. [108][109][110][111][112][113] For more information, readers are referred to the specific recommendations for perioperative assessment in the ACC/AHA 2008 ACHD CPG.…”

Preoperative cardiac risk stratification 2007: Evolving evidence, evolving strategies

“…A small retrospective review suggested that patients whose DES had been placed a median of 260 days before surgery had few cardiac events in the perioperative period. 17 The recommendations of a French task force did not provide strong guidance, probably because of a lack of evidence. 18 The only prospective study of stenting and noncardiac surgery involved continuing antiplatelet therapy (or stopping it less than 3 days before surgery) and using unfractionated heparin or enoxaparin in 103 patients.…”